Pan J et al. (Pan et al., 2022) integrated unbiased whole-genome CRISPR-Cas9 screen with database analysis indicated LAPTM5 (lysosomal protein transmembrane 5) as the critical contributor to LVN resistance in HCC. Here, LAPTM5 is linked to hepatocellular carcinoma.